[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2036562T3 - Un procedimiento para produccion de un derivado de pirrolidinamida. - Google Patents

Un procedimiento para produccion de un derivado de pirrolidinamida.

Info

Publication number
ES2036562T3
ES2036562T3 ES198787117003T ES87117003T ES2036562T3 ES 2036562 T3 ES2036562 T3 ES 2036562T3 ES 198787117003 T ES198787117003 T ES 198787117003T ES 87117003 T ES87117003 T ES 87117003T ES 2036562 T3 ES2036562 T3 ES 2036562T3
Authority
ES
Spain
Prior art keywords
chem
derivatives
production
derivative
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787117003T
Other languages
English (en)
Inventor
Masayuki Saitoh
Takaharu Tanaka
Naoki Higuchi
Masaki Hashimoto
Harukazu Fukami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2036562T3 publication Critical patent/ES2036562T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN NUEVO DERIVADO DE PIRROLIDINAMINA QUE MUESTRA ACTIVIDAD INHIBITORIA FRENTE A PROLIL ANDOPEPTIDASA Y SU USO COMO UN INHIBIDOR FRENTE A DICHO ENZIMA. LA PIRROLIDINOAMIDA DE LA INVENCION TIENE LA SIGUIENTE FORMULA GENERAL (I), DONDE R1 ES BENCILOXICARBONILO O UN GRUPO DE LA FORMULA (II), DONDE M ES UN NUMERO ENTERO DE 1 A 5 Y R2 ES UN GRUPO HIDROXI, ALCOXI O UN GRUPO DE LA FORMULA (III), DONDE R3 Y R4 SON, INDEPENDIENTEMENTE UNO DE OTRO, UN ATOMO DE HIDROGENO, UNO DE HALOGENO, UN ALQUILO INFERIOR O UN ALCOXI INFERIOR. SE PRESENTAN COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN TALES DERIVADOS JUNTO CON PROCESOS PARA LA PRODUCCION DE ESOS DERIVADOS JUNTO CON PROCESOS PARA LA PRODUCCION DE ESOS DERIVADOS. TAMBIEN SE INDICA EL USO DE LOS DERIVADOS PARA LA FABRICACION DE MEDICAMENTOS DE VALOR TERAPEUTICO.
ES198787117003T 1986-11-18 1987-11-17 Un procedimiento para produccion de un derivado de pirrolidinamida. Expired - Lifetime ES2036562T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61274355A JPH08806B2 (ja) 1986-11-18 1986-11-18 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体

Publications (1)

Publication Number Publication Date
ES2036562T3 true ES2036562T3 (es) 1993-06-01

Family

ID=17540501

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787117003T Expired - Lifetime ES2036562T3 (es) 1986-11-18 1987-11-17 Un procedimiento para produccion de un derivado de pirrolidinamida.

Country Status (9)

Country Link
US (1) US4810721A (es)
EP (1) EP0268281B1 (es)
JP (1) JPH08806B2 (es)
AT (1) ATE60579T1 (es)
AU (1) AU591860B2 (es)
CA (1) CA1326033C (es)
DE (1) DE3767839D1 (es)
ES (1) ES2036562T3 (es)
GR (1) GR3001405T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
DE3712364A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue pyrrolidin-2-(1,3-dicarbonyl)-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
CA2004028C (en) * 1988-12-08 1998-09-22 Motoki Torizuka Condensed benzene derivative
WO1990012005A1 (en) * 1989-04-13 1990-10-18 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5073549A (en) * 1990-03-22 1991-12-17 Bristol-Myers Squibb Company BU-4164E - A and B, prolyl endopeptidase inhibitors and their methods of use
US4999349A (en) * 1990-03-22 1991-03-12 Bristol-Myers Squibb Co. BU-4164E - A and B, prolyl endopeptidase inhibitors
US5506256A (en) * 1990-07-27 1996-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Proline derivatives possessing prolyl endopeptidase-inhibitory activity
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
IT1254471B (it) * 1992-02-27 1995-09-25 Magis Farmaceutici Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
JP3810097B2 (ja) * 1993-01-15 2006-08-16 明治製菓株式会社 ピロリジン−2−イルカルボニル複素環式化合物誘導体
DE602004026289D1 (de) 2003-05-05 2010-05-12 Probiodrug Ag Glutaminylcyclase-hemmer
ZA200603165B (en) 2003-11-03 2007-07-25 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
WO2005075436A2 (en) 2004-02-05 2005-08-18 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
DK2686313T3 (en) 2011-03-16 2016-05-02 Probiodrug Ag Benzimidazole derivatives as inhibitors of glutaminyl cyclase
DK3461819T3 (da) 2017-09-29 2020-08-10 Probiodrug Ag Inhibitorer af glutaminylcyklase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483991A (en) * 1983-01-17 1984-11-20 American Home Products Corporation Hypotensive agents
JPS60172929A (ja) * 1984-02-17 1985-09-06 Yakult Honsha Co Ltd 抗健忘症剤
JPS60188317A (ja) * 1984-03-09 1985-09-25 Yakult Honsha Co Ltd 抗健忘症剤
JPS6137764A (ja) * 1984-07-31 1986-02-22 Suntory Ltd 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物
IN164086B (es) * 1984-10-23 1989-01-14 Siemens Ag
JPH0680077B2 (ja) * 1985-02-08 1994-10-12 サントリー株式会社 プロリンエンドペプチダ−ゼインヒビタ−活性を有する新規ペプチド化合物
JPH0623190B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 インヒビタ−活性を有するn−アシルピロリジン誘導体及びその製法並びに用途
JPH0651677B2 (ja) * 1985-12-23 1994-07-06 サントリー株式会社 ジペプチド誘導体及びその製法並びに用途
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
JPH0780883B2 (ja) * 1986-03-27 1995-08-30 住友製薬株式会社 新規なβ−ラクタム化合物
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.

Also Published As

Publication number Publication date
JPH08806B2 (ja) 1996-01-10
JPS63130579A (ja) 1988-06-02
EP0268281B1 (en) 1991-01-30
EP0268281A3 (en) 1989-01-18
DE3767839D1 (de) 1991-03-07
AU591860B2 (en) 1989-12-14
US4810721A (en) 1989-03-07
ATE60579T1 (de) 1991-02-15
AU8133687A (en) 1988-05-19
EP0268281A2 (en) 1988-05-25
GR3001405T3 (en) 1992-09-25
CA1326033C (en) 1994-01-11

Similar Documents

Publication Publication Date Title
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
ES505960A0 (es) Un procedimiento para la obtencion de un derivado acilico sustituido del compuesto acido 1,2,3,4-tetrahidro-3-isoqui- nolein-carboxilico
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
BR0010555A (pt) Inibidores de neuraminidases
YU56995A (sh) Soli derivata indola
BG101422A (en) Benzoxazole derivatives as bronchodilating compounds
NO963370L (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
NO932147L (no) Antiallergiske forbindelser
ATE60763T1 (de) Pyrrolidinylamidesterderivate mit antiprolylendopeptidaseaktivitaet, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
JPS5665869A (en) Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug
MY105538A (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them.
AU7362587A (en) Variants of alpha1-antitrypsin which are useful, in particular, as kallikrein inhibitors
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
KR880007070A (ko) 백내장 치료용 약학 조성물
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
FR2380272A1 (fr) Derives de la coumarine et d'indane-diode, utilisables comme medicament
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
AU5977980A (en) Aminodeoxyclavulanic acids
NO924947L (no) Tetrazolderivater og legemidler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 268281

Country of ref document: ES